Dare Bioscience, Inc.
DARE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401914
No open-market purchases or sales by Dare Bioscience, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.75M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Dare Bioscience, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 36 | 28 | −8 |
| Shares | 6.82M | 7.22M | +392.5K (+5.8%) |
| Value | $3.35M | $2.46M | −$887.6K (−26.5%) |
New holders (3)
Institutions that held Dare Bioscience, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| AMH Equity Ltd | 923,619 | $310.4K | 0.46% |
| Cerity Partners LLC | 10,000 | $3.36K | 0.00% |
| Mather Group, LLC. | 1,000 | $490 | 0.00% |
Sold out (11)
Institutions that held Dare Bioscience, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Citadel Advisors LLC | 161,277 | $79.1K |
| Price T Rowe Associates Inc | 125,900 | $62.0K |
| Founders Financial Securities LLC | 124,000 | $60.8K |
| XTX Topco Ltd | 28,093 | $13.8K |
| Objectivity Squared, LLC | 27,000 | $12.9K |
| First Affirmative Financial Network | 12,211 | $5.99K |
| HighTower Advisors, LLC | 10,800 | $5.00K |
| First Pacific Financial | 10,000 | $4.90K |
| Wells Fargo & Company | 771 | $378 |
| GWM Advisors LLC | 10 | $5 |
| Capital Advisors, Ltd. LLC | 204 | $0 |